AU5744490A
(en)
*
|
1989-05-15 |
1990-12-18 |
Afferon Corporation |
Composition and method for neural desensitization
|
US5021450A
(en)
*
|
1989-05-30 |
1991-06-04 |
The United States Of America As Represented By The Secretary Of The Department Of Health And Human Services |
New class of compounds having a variable spectrum of activities for capsaicin-like responses, compositions and uses thereof
|
US5232684A
(en)
*
|
1990-06-29 |
1993-08-03 |
The United States Of America As Represented By The Department Of Health And Human Services |
Labelled resiniferatoxin, compositions thereof, and methods for using the same
|
JP2594485B2
(ja)
*
|
1990-08-29 |
1997-03-26 |
アメリカ合衆国 |
カプサイシンまたはその誘導体もしくは類似体を含有する鳥用食物
|
US5629045A
(en)
*
|
1992-09-17 |
1997-05-13 |
Richard L. Veech |
Biodegradable nosiogenic agents for control of non-vertebrate pests
|
US6063381A
(en)
*
|
1993-05-19 |
2000-05-16 |
Staggs; Jeff J. |
Therapeutic uses of pungent botanicals and their related compounds
|
US6635659B1
(en)
*
|
1995-03-20 |
2003-10-21 |
Arrie Kegler |
Topical formulation for arthritic symptoms treatment
|
US6248788B1
(en)
|
1996-11-06 |
2001-06-19 |
The Regents Of The University Of California |
Therapeutic method with capsaicin and capasicin analogs
|
US6239180B1
(en)
|
1995-11-08 |
2001-05-29 |
The Regents Of The University Of California |
Transdermal therapeutic device and method with capsaicin and capsaicin analogs
|
US5856361A
(en)
*
|
1996-04-23 |
1999-01-05 |
Medical Merchandising, Inc. |
Pain reliever and method of use
|
US5869533A
(en)
*
|
1996-04-23 |
1999-02-09 |
Holt; Stephen D. |
Non-irritating capsaicin formulations and applicators therefor
|
WO1998009620A1
(en)
*
|
1996-09-05 |
1998-03-12 |
Research Development Foundation |
INHIBITION OF NUCLEAR TRANSCRIPTION FACTOR NF-λB BY CAFFEIC ACID PHENETHYL ESTER (CAPE), DERIVATIVES OF CAPE, CAPSAICIN (8-METHYL-N-VANILLYL-6-NONENAMIDE) AND RESINIFERATOXIN
|
AU5460598A
(en)
*
|
1996-11-15 |
1998-06-03 |
United States Of America, Represented By The Secretary, Department Of Health And Human Services, The |
Pharmaceutical compositions containing vanilloid agonists in combination with vanilloid antagonists
|
US5962532A
(en)
*
|
1997-03-13 |
1999-10-05 |
Campbell; James N. |
Therapeutic method with capsaicin and capsaicin analogues
|
EP1014957A4
(en)
*
|
1997-08-28 |
2004-01-28 |
Afferon Corp |
URINARY INCONTINENCE THERAPY
|
US6790207B2
(en)
|
1998-06-04 |
2004-09-14 |
Curon Medical, Inc. |
Systems and methods for applying a selected treatment agent into contact with tissue to treat disorders of the gastrointestinal tract
|
US20110071468A1
(en)
*
|
1998-06-04 |
2011-03-24 |
Mederi Therapeutics, Inc. |
Systems and methods for applying a selected treatment agent into contact with tissue to treat sphincter dysfunction
|
US6802841B2
(en)
*
|
1998-06-04 |
2004-10-12 |
Curon Medical, Inc. |
Systems and methods for applying a selected treatment agent into contact with tissue to treat sphincter dysfunction
|
US6348501B1
(en)
|
1999-09-29 |
2002-02-19 |
Medical Merchandising, Inc. |
Lotion compositions utilizing capsaicin
|
US6653352B2
(en)
|
1999-09-29 |
2003-11-25 |
Medical Merchandising, Inc. |
Pain reliever and method of use
|
US6197823B1
(en)
|
1999-09-29 |
2001-03-06 |
Medical Merchandising, Inc. |
Pain reliever and method of use
|
CN1443170A
(zh)
*
|
2000-07-20 |
2003-09-17 |
神经原公司 |
辣椒素受体配体
|
US20040146590A1
(en)
|
2001-03-22 |
2004-07-29 |
Iadarola Michael J |
Molecular neurochirurgie for pain control administering locally capsaicin or resinferatoxin
|
US20060240125A1
(en)
*
|
2005-04-21 |
2006-10-26 |
Astrup Arne V |
Composition for affecting weight loss
|
US20030068375A1
(en)
|
2001-08-06 |
2003-04-10 |
Curtis Wright |
Pharmaceutical formulation containing gelling agent
|
US20030044458A1
(en)
|
2001-08-06 |
2003-03-06 |
Curtis Wright |
Oral dosage form comprising a therapeutic agent and an adverse-effect agent
|
WO2003062209A2
(en)
*
|
2002-01-17 |
2003-07-31 |
Neurogen Corporation |
Substituted quinazolin-4-ylamine analogues as modulators of capsaicin
|
US20040126430A1
(en)
|
2002-09-05 |
2004-07-01 |
Angel Arturo J. |
Compositions and kits for the removal of irritating compounds from bodily surfaces
|
EP2422773A3
(en)
|
2002-09-20 |
2012-04-18 |
Alpharma, Inc. |
Sequestering subunit and related compositions and methods
|
DK1587506T3
(da)
*
|
2002-12-18 |
2008-11-24 |
Algorx |
Administration af capsaicinoider
|
CA2510181C
(en)
|
2002-12-18 |
2011-03-08 |
Algorx Pharmaceuticals, Inc. |
Administration of capsaicinoids
|
BRPI0409748A
(pt)
*
|
2003-04-08 |
2006-10-24 |
Algorx Pharmaceuticals Inc |
preparação e purificação de capsaicin sintetico
|
US20040224037A1
(en)
*
|
2003-04-28 |
2004-11-11 |
Gonzalo Romero-Matos |
Devastating treatment against hiv/aids with capsaicin
|
US8802139B2
(en)
*
|
2003-06-26 |
2014-08-12 |
Intellipharmaceutics Corp. |
Proton pump-inhibitor-containing capsules which comprise subunits differently structured for a delayed release of the active ingredient
|
HUE037643T2
(hu)
|
2004-06-12 |
2018-09-28 |
Collegium Pharmaceutical Inc |
Visszaélésre nem alkalmas gyógyszerkészítmények
|
US8394409B2
(en)
*
|
2004-07-01 |
2013-03-12 |
Intellipharmaceutics Corp. |
Controlled extended drug release technology
|
US10624858B2
(en)
|
2004-08-23 |
2020-04-21 |
Intellipharmaceutics Corp |
Controlled release composition using transition coating, and method of preparing same
|
WO2006058140A2
(en)
*
|
2004-11-24 |
2006-06-01 |
Algorx Pharmaceuticals, Inc. |
Capsaicinoid gel formulation and uses thereof
|
PL1838301T3
(pl)
*
|
2004-12-28 |
2015-08-31 |
Mestex Ag |
Użycie resiniferatotoksyny (RTX) dla wytwarzania środka leczącego stany bólowe
|
MX2007008866A
(es)
*
|
2005-01-28 |
2007-09-11 |
Archer Daniels Midland Co |
Composiciones alimenticias para animales capaces de reducir la incidencia de toxicosis de festuca en mamiferos.
|
PT1865941E
(pt)
*
|
2005-04-01 |
2011-01-05 |
Neurogesx Inc |
Óleos de capsaicinóides e métodos para a sua produção e utilização
|
US10064828B1
(en)
|
2005-12-23 |
2018-09-04 |
Intellipharmaceutics Corp. |
Pulsed extended-pulsed and extended-pulsed pulsed drug delivery systems
|
EP2007222B1
(en)
*
|
2006-03-10 |
2017-05-03 |
Archer Daniels Midland Company |
Methods and compositions for increased productivity in animals
|
CN101453993A
(zh)
*
|
2006-04-03 |
2009-06-10 |
伊萨·奥迪迪 |
含有机溶胶涂层的受控释放递送物件
|
US10960077B2
(en)
|
2006-05-12 |
2021-03-30 |
Intellipharmaceutics Corp. |
Abuse and alcohol resistant drug composition
|
CN101677963B
(zh)
|
2006-06-19 |
2012-05-30 |
奥尔制药公司 |
药物组合物
|
US7645767B2
(en)
*
|
2006-08-31 |
2010-01-12 |
Trinity Laboratories, Inc. |
Pharmaceutical compositions for treating chronic pain and pain associated with neuropathy
|
WO2008109026A1
(en)
*
|
2007-03-05 |
2008-09-12 |
Mt Cook Pharma |
Pharmaceutical compositions for the localized treatment of neurogenic dysfunction
|
US8233976B2
(en)
|
2007-12-05 |
2012-07-31 |
The Invention Science Fund I, Llc |
System for transdermal chemical modulation of neural activity
|
US8165669B2
(en)
|
2007-12-05 |
2012-04-24 |
The Invention Science Fund I, Llc |
System for magnetic modulation of neural conduction
|
US8195287B2
(en)
|
2007-12-05 |
2012-06-05 |
The Invention Science Fund I, Llc |
Method for electrical modulation of neural conduction
|
US8165668B2
(en)
|
2007-12-05 |
2012-04-24 |
The Invention Science Fund I, Llc |
Method for magnetic modulation of neural conduction
|
US8170659B2
(en)
*
|
2007-12-05 |
2012-05-01 |
The Invention Science Fund I, Llc |
Method for thermal modulation of neural activity
|
US8170658B2
(en)
*
|
2007-12-05 |
2012-05-01 |
The Invention Science Fund I, Llc |
System for electrical modulation of neural conduction
|
US8160695B2
(en)
|
2007-12-05 |
2012-04-17 |
The Invention Science Fund I, Llc |
System for chemical modulation of neural activity
|
US8180446B2
(en)
*
|
2007-12-05 |
2012-05-15 |
The Invention Science Fund I, Llc |
Method and system for cyclical neural modulation based on activity state
|
US20090149799A1
(en)
*
|
2007-12-05 |
2009-06-11 |
Searete Llc, A Limited Liability Corporation Of The State Of Delaware |
Method for chemical modulation of neural activity
|
US8987328B2
(en)
|
2008-10-30 |
2015-03-24 |
Trinity Laboratories, Inc. |
Esters of capsaicinoids as dietary supplements
|
US20100303932A1
(en)
*
|
2009-05-28 |
2010-12-02 |
Baskaran Thyagarajan |
Method for Attenuating the Effects of Botulinum Toxin
|
US20110135627A1
(en)
*
|
2009-10-07 |
2011-06-09 |
The Inflasoothe Group, Inc. |
Pain relief composition, system and method
|
US10668060B2
(en)
|
2009-12-10 |
2020-06-02 |
Collegium Pharmaceutical, Inc. |
Tamper-resistant pharmaceutical compositions of opioids and other drugs
|
US20130247383A1
(en)
|
2010-07-19 |
2013-09-26 |
3M Innovative Properties Company |
Hand tool with replaceable knife cartridge
|
EP2629610B1
(en)
|
2010-07-27 |
2017-09-06 |
Flex Pharma, Inc. |
Methods and compositions for preventing and relieving muscle cramps and for recovery from neuromuscular irritability and fatigue following exercise
|
EP2826469A1
(en)
|
2010-12-22 |
2015-01-21 |
Purdue Pharma L.P. |
Encased tamper resistant controlled release dosage forms
|
CA2822769C
(en)
|
2010-12-23 |
2016-10-04 |
Purdue Pharma L.P. |
Tamper resistant solid oral dosage forms
|
EP2953618B1
(en)
|
2013-02-05 |
2020-11-11 |
Purdue Pharma L.P. |
Tamper resistant pharmaceutical formulations
|
US10751287B2
(en)
|
2013-03-15 |
2020-08-25 |
Purdue Pharma L.P. |
Tamper resistant pharmaceutical formulations
|
US9956166B2
(en)
|
2013-09-18 |
2018-05-01 |
Sorrento Therapeutics, Inc. |
Methods for administration and methods for treating cardiovascular diseases with resiniferatoxin
|
CA2910865C
(en)
|
2014-07-15 |
2016-11-29 |
Isa Odidi |
Compositions and methods for reducing overdose
|
US9737530B1
(en)
|
2016-06-23 |
2017-08-22 |
Collegium Pharmaceutical, Inc. |
Process of making stable abuse-deterrent oral formulations
|
WO2018136943A1
(en)
|
2017-01-23 |
2018-07-26 |
Flex Pharma, Inc. |
Compositions and methods affecting exercise performance
|
US11707437B2
(en)
|
2019-07-12 |
2023-07-25 |
Board Of Trustees Of Southern Illinois University |
Topical formulations with resiniferatoxin nanoparticles and methods
|